Growing community of inventors

Mittelbiberach, Germany

Jochen Neu

Average Co-Inventor Count = 13.72

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 25

Jochen NeuDaniel Kuzmich (2 patents)Jochen NeuHossein Razavi (2 patents)Jochen NeuAlan David Swinamer (2 patents)Jochen NeuBrian Nicholas Cook (2 patents)Jochen NeuCan Mao (2 patents)Jochen NeuPingrong Liu (2 patents)Jochen NeuJohn Lord (2 patents)Jochen NeuChristian Harcken (2 patents)Jochen NeuBrian Christopher Raudenbush (2 patents)Jochen NeuThomas Wai-ho Lee (2 patents)Jochen NeuJinhua Jeff Song (1 patent)Jochen NeuJonathan Timothy Reeves (1 patent)Jochen NeuZhulin Tan (1 patent)Jochen NeuDarren DiSalvo (1 patent)Jochen NeuDaniel Robert Fandrick (1 patent)Jochen NeuDarren Di Salvo (1 patent)Jochen NeuThomas Wai-Ho Lee (0 patent)Jochen NeuJochen Neu (2 patents)Daniel KuzmichDaniel Kuzmich (27 patents)Hossein RazaviHossein Razavi (25 patents)Alan David SwinamerAlan David Swinamer (16 patents)Brian Nicholas CookBrian Nicholas Cook (13 patents)Can MaoCan Mao (13 patents)Pingrong LiuPingrong Liu (12 patents)John LordJohn Lord (11 patents)Christian HarckenChristian Harcken (5 patents)Brian Christopher RaudenbushBrian Christopher Raudenbush (4 patents)Thomas Wai-ho LeeThomas Wai-ho Lee (3 patents)Jinhua Jeff SongJinhua Jeff Song (18 patents)Jonathan Timothy ReevesJonathan Timothy Reeves (12 patents)Zhulin TanZhulin Tan (12 patents)Darren DiSalvoDarren DiSalvo (9 patents)Daniel Robert FandrickDaniel Robert Fandrick (6 patents)Darren Di SalvoDarren Di Salvo (1 patent)Thomas Wai-Ho LeeThomas Wai-Ho Lee (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Boehringer Ingelheim International Gmbh (2 from 1,537 patents)


2 patents:

1. 8063065 - Azaindazole compounds as CCR1 receptor antagonists

2. 7879873 - Azaindazole compounds as CCR1 receptor antagonists

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/11/2026
Loading…